Key Highlights
- Wells Fargo elevated OSCR from Underweight to Equal Weight, increasing the price target from $11 to $20
- Shares are trading around $20.50, reflecting a 43% gain year-to-date
- In Florida, representing approximately 64% of premium revenue, enrollment declined 13.5% year-over-year while medical loss ratios improved by 370 basis points
- First quarter 2026 earnings per share reached $2.07, significantly exceeding the $1.06 consensus forecast
- Wall Street analysts show increased confidence in 2026 performance, though cautioning about limited long-term visibility
Oscar Health (OSCR) experienced a notable surge Wednesday following Wells Fargo’s decision to upgrade the health insurer and substantially increase its price objective, propelling shares upward by approximately 14% during the trading session.
Wells Fargo’s Stephen Baxter, serving as the covering analyst, shifted his rating on OSCR from Underweight to Equal Weight while simultaneously elevating the price target from $11 to $20. At the moment of the upgrade announcement, the equity was changing hands near the $20.50 level.
The rating adjustment followed Wells Fargo’s comprehensive examination of statutory regulatory filings, which revealed that both enrollment figures and morbidity patterns across health insurance exchanges are demonstrating stronger performance than anticipated throughout 2026.
The broader insurance sector is experiencing meaningful enhancement in medical loss ratio metrics, while companies appear to be adopting more conservative approaches to risk adjustment accounting compared to the previous year — a development Wells Fargo interprets favorably.
Baxter indicated the firm has grown more confident regarding the exchange marketplace trajectory for 2026, though he emphasized that projections extending past that timeframe remain uncertain. Payment integrity continues to be monitored as a critical focus area.
Performance in the Sunshine State
Florida represents Oscar’s largest geographic market, generating approximately 64% of total premium income. While membership in the state contracted 13.5% on a year-over-year basis, the medical loss ratio demonstrated a significant 370 basis point enhancement during the comparable timeframe.
Wells Fargo additionally identified approximately 640 basis points of conservative positioning in Oscar’s risk adjustment accounting methodology for Florida — a situation that stands in stark contrast to the approach observed during the prior year.
Heading into Wednesday’s session, Oscar had already accumulated a 43% advance year-to-date, with shares positioned near $20.50 before the upgrade announcement provided additional upward momentum.
Notwithstanding the rally, the stock exhibited some volatility throughout the day’s trading. Market participants appeared to be balancing concerns about uncertain longer-term outlook against the encouraging near-term operational improvements.
Quarterly Performance and Executive Transition
Oscar Health disclosed first quarter 2026 earnings per share of $2.07, representing nearly double the $1.06 Wall Street consensus projection. Conversely, revenue figures fell short of analyst expectations during the identical reporting period.
Analyst projections indicate Oscar Health will achieve full-year profitability in 2026, with three analysts having recently increased their earnings forecasts.
Regarding organizational leadership, co-founder Mario Schlosser transitioned away from his positions as President of Technology and Chief Technology Officer. He assumed a new capacity as Co-Founder and Advisor to the CEO, where he will continue contributing to Oscar’s artificial intelligence initiatives and digital health strategy while maintaining his board membership.
The company maintains a market capitalization of approximately $6.37 billion. Daily trading volume typically averages around 7.16 million shares.
Wells Fargo’s upgrade reflects a broader pattern of analysts adopting increasingly optimistic positions on Oscar’s near-term prospects based on preliminary 2026 exchange market information.
